Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint/openWorldHint/idempotentHint, and the description adds substantial non-obvious behavior beyond them: sources_used/sources_failed expose per-company data availability, 'an empty section is a real no-data, not a bug,' GDELT→GNews fallback, and the expectation that small-molecule-only companies legitimately show no fda_products. The resolved_from/resolved_to nuance for name inputs and the private-company behavior also clarify edge-case outputs. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and almost every sentence carries real information — the source fan-out list, per-section return semantics, and failure handling are all earned. However, it is a single dense run-on paragraph, the opening example list is longer than needed to establish intent, and the final sentence on type/value restates the schema's enum description, which is redundant structured data.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a high-complexity tool with no output schema, the description carries the full burden and does so thoroughly: it enumerates every return section (cik, company_name, recent_filings with pipeworx URIs, fundamentals, patents, contracts, fda_products, hiring, news, LEI), all data sources, and the error semantics (empty sections, private companies, resolved:false). The only small gaps — unspecified news item count and the slightly ambiguous 'patents (USPTO) — one item' — do not impede correct invocation or interpretation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3; the schema already documents type's enum and value's ticker/CIK/name formats. The description adds concrete examples ('AAPL', '0000320193', 'Moderna') and the resolved_from/resolved_to nuance, but it also duplicates what the schema already states ('type accepts company or ticker interchangeably — both take the same value shapes'), so added meaning over the schema is only marginal.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete utterance patterns and a precise scope statement — 'full cross-source profile of a US public company in ONE parallel call' — giving a specific verb+resource+scope. It clearly differentiates from siblings by listing exactly what the tool fans out to (SEC EDGAR, XBRL, USPTO, USAspending, Purple Book, DOL LCA, news, GLEIF) and declaring 'ALWAYS PREFER over chaining single-pack lookups,' which makes it unmistakable versus resolve_entity, compare_entities, or targeted searches.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit routing logic: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also defines boundary conditions — a private company without CIK/ticker returns resolved:false with a notes line, not a failure — and specifies accepted input formats (ticker, zero-padded CIK, company name), so an agent knows exactly when to invoke and what to expect in edge cases.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Many tools serve overlapping purposes, such as the three ask_pipeworx variants (stable, beta, grounded) and the six Polymarket-specific tools. While detailed descriptions help distinguish them, an agent could still confuse bet_research with polymarket_edges or the ask_pipeworx versions.

Naming Consistency2/5

Naming is highly inconsistent: verb_noun (ask_pipeworx, compare_entities), noun_noun (bet_research, entity_profile), single verbs (forget, recall, search), and adjective_noun (recent_alerts, deep_research). No clear pattern emerges across the set.

Tool Count3/5

33 tools is on the high side for a server named 'Smithsonian' that actually covers a broad range of data sources (SEC, FDA, Polymarket, npm, etc.). The number feels borderline heavy but is still manageable if the server's true purpose is general research.

Completeness4/5

The tool set covers multiple domains (company financials, drugs, economics, prediction markets, npm, museum data) with reasonable depth. Minor gaps exist, such as lack of PyPI scanning or missing update/delete operations for some memory features, but core workflows are well-supported.